Mankind Pharma Limited has informed the Exchange about submission of application for reclassification
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has submitted an application to BSE and NSE on August 3, 2025, seeking reclassification of Ayushi and Poonam Estates LLP from the 'Promoter & Promoter Group' category to the 'Public' category. This is being done under Regulation 31A(3) of SEBI's Listing Regulations and follows a board meeting held on July 31, 2025. The reclassification does not involve any sale of shares but only changes the category classification of the existing holding. The specific shareholding percentage of the LLP is not disclosed in the filing.
If approved, this reclassification would reduce the official promoter group shareholding and increase the public shareholding of Mankind Pharma, potentially making the stock more accessible to a broader investor base. Share prices are unlikely to move significantly since no shares are being sold — only the classification is changing.